Trailing-twelve-month (TTM) revenue is $112.41 Million with a year-over-year growth of (18.86%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $27,085,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-05 |
| Q4 FY2025Period ended 2025-12-31 | $26,763,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-09 |
| Q1 FY2026Period ended 2026-03-31 | $27,925,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-08 |
| Q2 FY2026Period ended 2026-06-30 | $30,639,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-07 |
| TTM revenue | $112,412,000 |
Current P/S: $266,099,839 market capitalization ÷ $112,412,000 TTM revenue = 2.37x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T16:40:14.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $30.64M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:43:57.524Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Other Revenues | $5M | $7M | $9M | $3M | $1M | $6M |
| Product And Services | $166M | $227M | $378M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Africa | N/A | N/A | N/A | N/A | $33M | $24M |
| Europe | $12M | $14M | $12M |
$112.41M
$112.41 Million
(18.86%)
vs. $138.54M a year ago (TTM)
(13.12%)
5 Year compound annual growth rate
1 Year
(18.86%)
3 Year
(38.35%)
5 Year
(13.12%)
10 Year
(0.87%)
15 Year
+2.80%
20 Year
+2.48%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $115.02M | ($70.81M) | (38.10%) |
| 2024 | $185.83M | ($219.65M) | (54.17%) |
| 2023 | $405.47M | +$17.99M | +4.64% |
| 2022 | $387.48M | +$153.81M | +65.82% |
| 2021 | $233.67M | +$61.95M | +36.08% |
| 2020 |
TTM Growth
(18.86%)
3-Year CAGR
(38.35%)
5-Year CAGR
(13.12%)
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-10-06T16:43:57.524Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $185M |
| $109M |
| $8M |
| $7M |
| Other Foreign Countries | $29M | $31M | $26M | $36M | $5M | $5M |
|---|
| UNITED STATES | $131M | $188M | $350M | $362M | $139M | $78M |
|---|
| $171.72M |
| +$17.12M |
| +11.07% |
| 2019 | $154.60M | ($27.14M) | (14.93%) |
| 2018 | $181.74M | +$14.68M | +8.79% |
| 2017 | $167.06M | +$44.27M | +36.05% |
| 2016 | $122.80M | +$3.08M | +2.57% |
